Could these small-cap growth stars fund your retirement?

These two growth stocks are looking to profit from their leading positions in niche markets.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Avon Rubber (LSE: AVON) is far from a household name but the share price of the £300m market cap manufacturer has nearly tripled over the past five years, which makes the company well worth taking a look at.

First off, this stellar share price performance isn’t without good cause as the company’s earnings per share have risen from 26.9p in 2012 to 74.2p last year. This growth has been driven by both organic expansion and a series of acquisitions that have increased the company’s product range for both its dairy solutions and protective masks for militaries and emergency personnel.

The European dairy market has been through the ringer of late as a global supply glut drove down prices and reduced demand for Avon’s products. However, management has taken this as an opportunity to increase market share and transition sales to its in-house-manufactured products that offer higher margins. With dairy prices beginning to rebound and farmers once again investing in their farms, Avon is already benefitting as dairy division revenue rose 22% year-on-year in H1 to £25.2m.

Sales of the group’s protective respiratory systems also rose by 22% to £55.9m as the US Department of Defense ordered high volumes of equipment and overseas demand increased substantially. Stripping out the positive effects of the weak pound did lower group revenue growth to 7%, but this is still a very healthy amount.

While group margins stayed level, profits and cash generation rose in line with sales growth and the company ended H1 with £12.6m in net cash, which supported a whopping 30% increase in the interim dividend. The company’s outlook over the long term will still be influenced by the cyclical nature of its two markets, but management is doing well to re-invest cash in expanding its portfolio of brands and pushing into new regions. With its shares priced at just 14 times forward earnings, I reckon investors would do well to dig deeper into Avon Rubber.

Finally turning a corner?

One small-cap offering a much higher ceiling but with much more risk for investors is Ceres Power (LSE: CWR). The company’s SteelCell fuel cell technology has long been lauded as the next big thing in a world seeking to lower carbon emissions, but so far the company has had little luck commercialising its product since going public over a decade ago.

That said, there have been tangible improvements in recent years under a new leadership team that has signed partnership agreements with major players in the automotive, energy and data centre sectors to utilise the SteelCell product to reduce operating costs and trim emissions.

The benefits of these agreements are starting to flow through to the company’s financial statements as revenue for the year to June more than doubled to £4.1m and its order book increased to £3.2m. Unfortunately, sales still do not cover operating expenditures and pre-tax losses for the year were £9.4m.

While losses are narrowing the company is still reliant on shareholders to fund itself through rights issues such as the one in October that raised £20m. Ceres’ SteelCell technology certainly has high potential to reduce energy costs for consumers and business alike, but investing in lossmaking small-caps is simply too risky for me so my interest will remain academic for now.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Ian Pierce has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

After it crashed 25%, should I buy this former stock market darling in my Stocks and Shares ISA?

Harvey Jones has a big hole in his Stocks and Shares ISA that he is keen to fill. Should he…

Read more »

happy senior couple using a laptop in their living room to look at their financial budgets
Investing Articles

How’s the dividend forecast looking for Legal & General shares in 2025 and beyond?

As a shareholder, I like to keep track of the potential dividend returns I could make from my Legal &…

Read more »

artificial intelligence investing algorithms
Investing Articles

Could buying this stock with a $7bn market cap be like investing in Nvidia in 2010?

Where might the next Nvidia-type stock be lurking in today's market? Our writer takes a look at one candidate with…

Read more »

Investing Articles

Is GSK a bargain now the share price is near 1,333p?

Biopharma company GSK looks like a decent stock to consider for the long term, so is today's lower share price…

Read more »

Snowing on Jubilee Gardens in London at dusk
Investing Articles

Could December be a great month to buy UK shares?

Christopher Ruane sees some possible reasons to look for shares to buy in December -- but he'll be using the…

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

Sticking to FTSE shares, I’d still aim for a £1,000 monthly passive income like this!

By investing in blue-chip FTSE shares with proven business models, our writer hopes he can build sizeable passive income streams…

Read more »

Growth Shares

BT shares? I think there are much better UK stocks for the long term

Over the long term, many UK stocks have performed much better than BT. Here’s a look at two companies that…

Read more »

British Pennies on a Pound Note
Investing Articles

After a 540% rise, could this penny share keep going?

This penny share has seen mixed fortunes in recent years. Our writer looks ahead to some potentially exciting developments in…

Read more »